source
- Iambic Therapeutics raises $150 million in IPO to fund oncology drug developmentIambic Therapeutics, a San Diego-based AI biotech, completed an initial public offering that raised $150 million, exactly meeting its goal of selling 9.4 million shares at $16 each. The company sa…
- Iambic Therapeutics raises $150 million in IPO, begins Nasdaq trading under ticker IAMIambic Therapeutics, an AI-driven drug discovery startup, completed an initial public offering that raised $150 million. The company sold about 9.4 million shares at $16 each and will start tradin…